I now have comprehensive information from multiple authoritative textbooks. Let me compose the full detailed answer.
Managing Blood Sugar in a Diabetic Patient on Steroids (Glucocorticoid-Induced Hyperglycemia)
Why Steroids Raise Blood Sugar
Glucocorticoids drive hyperglycemia through three simultaneous mechanisms:
- Enhanced hepatic gluconeogenesis - the liver makes more glucose
- Decreased peripheral insulin-mediated glucose uptake - muscle and fat cells become insulin resistant (reduced receptor affinity)
- Impaired insulin secretion from pancreatic beta cells
The result is worsening glycemic control in known diabetics AND new-onset hyperglycemia in previously normal individuals. The effect is dose-dependent, usually reversible, and most pronounced postprandially (after meals), especially when the steroid is given in the morning. - Harrison's Principles of Internal Medicine 22E, p.1411
Step 1 - Assess Severity
| Fasting Plasma Glucose (FPG) | Approach |
|---|
| Near normal range | Oral agents may be sufficient (sulfonylurea or metformin) |
| >200 mg/dL (11.1 mmol/L) | Oral agents usually not sufficient - insulin therapy required |
| >250-300 mg/dL with symptoms | Start insulin immediately |
Harrison's, p.1411; Tintinalli's Emergency Medicine, p.1465
Step 2 - Insulin Strategy
For Patients Already on Insulin (Pre-existing Diabetes)
Do NOT simply increase the basal (long-acting) insulin dose as a reflex - this can cause dangerous hypoglycemia, especially overnight, because glucocorticoids mainly cause postprandial hyperglycemia (not fasting). - Tintinalli's, p.1465
The correct approach:
A. Morning steroid dose (most common scenario - e.g., once-daily prednisone in the morning):
- Add NPH insulin or short-acting insulin in the morning to cover the postprandial glucose surge
- The glucose spike typically peaks in the afternoon (4-10 hours post-dose)
- Preferred regimen: NPH given at the same time as morning steroid - its peak action coincides with the steroid's peak glucose-raising effect
- Alternatively, increase rapid-acting (prandial) bolus doses at breakfast and lunch
B. Multiple-dose or evening steroid regimens:
- More complex, may require increasing both basal and prandial insulin
- Requires more frequent glucose monitoring
C. Monitoring:
- Check blood glucose before meals AND 2 hours after meals - especially afternoon readings
- If on once-daily morning steroid, pre-bed glucose may be less affected than lunchtime glucose
Step 3 - Insulin Dose Adjustments by Steroid Dose
| Prednisone Equivalent Daily Dose | Suggested NPH/Insulin Supplement |
|---|
| Low dose (<10 mg/day) | May need only 10-20% increase in current insulin or small NPH add-on |
| Moderate (10-40 mg/day) | 0.1-0.2 units/kg of NPH added in the morning |
| High dose (>40 mg/day) | Significant dose escalation needed; consider basal-bolus regimen |
Step 4 - Which Insulin Type to Use
- NPH (intermediate-acting) given with the morning steroid is often the most practical and cost-effective choice - its timing matches prednisone's glucose-raising window
- Rapid-acting analogues (lispro, aspart, glulisine) can be added as prandial boluses
- For hospital or high-dose steroid settings, an IV insulin infusion may be needed; target glucose 140-180 mg/dL in most inpatients
- Pre-mixed (mixed) insulin can also improve control of prednisolone-induced hyperglycemia (Scholes et al., 2023 - PMID 36880383)
Step 5 - Watch for Hypoglycemia
This is one of the most dangerous pitfalls:
- Hypoglycemia commonly occurs when the steroid dose is reduced without a corresponding reduction in insulin
- Also occurs if the patient fasts or skips meals while on the increased insulin dose
- Always reduce insulin when tapering steroids
- Oral glucose-lowering agents (sulfonylureas especially) carry hypoglycemia risk during fasting - Harrison's, p.1396
- Avoid metformin in acutely ill/hospitalized patients due to lactic acidosis risk
Step 6 - Monitoring Protocol
- Fasting blood glucose every morning
- Pre-meal and 2-hour post-meal glucose checks (especially post-breakfast and post-lunch)
- HbA1c to assess long-term control
- Periodic renal function if on metformin
- Alternate-morning steroid schedules are NOT recommended in diabetic patients - they cause wide fluctuations in insulin requirements - Dermatology 2-Volume Set 5e, p.4524
Step 7 - When Steroids Are Stopped
- Hyperglycemia often resolves spontaneously once glucocorticoids are discontinued
- Reduce insulin progressively as steroid is tapered - failure to do so causes hypoglycemia
- Monitor glucose closely during and after taper
- Some patients who developed "steroid-induced diabetes" may return to normal, but some will remain diabetic if the steroid unmasked an underlying predisposition
Key Points Summary
| Situation | Action |
|---|
| FPG near normal on steroids | Oral agents (sulfonylurea/metformin) first |
| FPG >200 mg/dL | Start insulin |
| Once-daily morning steroid | Add morning NPH; increase prandial insulin at breakfast/lunch |
| Steroid being tapered | Reduce insulin proportionally to avoid hypoglycemia |
| Hospitalized patient | IV insulin or SC basal-bolus; target 140-180 mg/dL |
| Steroid stopped | Monitor for glucose normalization; wean insulin carefully |
Key references:
- Harrison's Principles of Internal Medicine 22E - Glucocorticoids section, p.1411
- Tintinalli's Emergency Medicine - Glucocorticoid Therapy section, p.1465
- Dermatology 2-Volume Set 5e - Metabolic Effects section, p.4524
- Goodman & Gilman's Pharmacological Basis of Therapeutics - Chronic Use of Supraphysiologic Glucocorticoid Doses, p.1032
- Glucocorticoid-Induced Hyperglycemia: A Neglected Problem - Cho JH & Suh S, Endocrinol Metab, 2024 (PMID 38532282)
- New Algorithm for Pharmacotherapy of Steroid-Induced Diabetes - Ostrowska-Czyzewska et al., J Clin Med, 2024 (PMID 39407860)